Table S4 from Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312

2026 Open access

Read full text
Authors: Peng George Wang, Xin Sun, Xueting He, Di Kang, Xiaoyu Liu, Dan Liu, Amin Li, Guiqun Yang, Yiwei Lin, Sujing Li, Yinxiang Wang, Yanping Wang
DOI: 10.1158/2767-9764.31761874
Cited by: 0

Abstract

Table S4 shows kinases list in an order from strong to weak by inhibition rate of 10 μM glecirasib.

Fields of Study & Subjects

Protein Kinase Regulation and GTPase Signaling Melanoma and MAPK Pathways Protein Tyrosine Phosphatases

Publication details

Publication date
16 March 2026
Language
EN